Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on July 19, 2019, 10:47:25 am

Title: Epclusa and Mavyret Cure Hep C in Nearly Everyone in Real-World Settings
Post by: Hep Editors on July 19, 2019, 10:47:25 am

Gilead Sciences’ Epclusa (sofosbuvir/velpatasvir) and AbbVie’s Mavyret (glecaprevir/pibrentasvir) have very high hepatitis C virus (HCV) cure rates in real-world use, aidsmap reports. Both regimens are approved to treat all genotypes of the virus.

Researchers presented findings from a pair of real-world studies, one for each of the regimens, at the 53rd International Liver Congress in Vienna.

Read more...
https://www.hepmag.com/article/epclusa-mavyret-cure-hep-c-nearly-everyone-realworld-settings